30+
COUNTRIES
50k+
TONS ANNUAL CAPACITY
GRS / FDA
CERTIFIED
90%
CARBON REDUCTION
At RePlastic Global, we are dedicated to driving the circular economy through sustainable material innovation. As a leading manufacturer and global distributor, we specialize in high-purity, GRS (Global Recycled Standard) and FDA-certified recycled R-PET flakes and pellets, alongside eco-friendly bio-plasticizers.
Our state-of-the-art manufacturing facilities boast an annual production capacity of over 50,000 tons, ensuring a reliable, scalable, and high-quality supply chain for industrial brands worldwide. Operating across more than 30 countries, we empower businesses to achieve their environmental, social, and governance (ESG) goals by delivering sustainable alternatives that achieve up to a 90% carbon reduction compared to virgin polymers.
Through rigorous quality control, advanced decontamination technologies, and strict regulatory compliance, RePlastic Global is your trusted partner in closing the loop on plastic waste and transforming sustainable vision into measurable global impact.
Our Innovative Recycling Solutions
Explore our high-quality recycled plastics and bio-based products, designed for a sustainable future.
Our Commitment to Circularity
RePlastic Global is dedicated to advancing the circular economy by transforming plastic waste into high-quality recycled materials, reducing environmental impact, and promoting sustainable industry practices.
Manufacturing Scales & Capacity
Industry Insights & News
PLA, PBAT, or PBS? How to Choose the Right Biodegradable Polymer for Your Business
As global environmental regulations tighten and consumer demand for eco-friendly packaging soars, the plastics industry
MCCP vs. LCCP: Navigating the Chlorinated Paraffin Shift in 2026
The chlorinated paraffin market is pivoting from SCCPs to MCCPs and LCCPs as global phase-outs
PEI Pellets: A New Engineering Plastic Choice for Medical and 5G Applications
Polyetherimide (PEI) pellets, with their excellent flame retardancy, dimensional stability, and biocompatibility, are becoming key


